West Pharmaceutical Services, Inc. Share Price
Equities
WST
US9553061055
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 243.61 USD | -1.04% |
|
+2.77% | -11.46% |
| 02-12 | West Pharma forecasts 2026 profit above estimates on strong demand for drug components | RE |
| 02-12 | West Pharma forecasts 2026 profit above estimates on strong demand for drug components | RE |
| Capitalization | 17.71B 14.92B 13.63B 13B 24.1B 1,603B 24.98B 158B 62.8B 773B 66.41B 65.05B 2,705B | P/E ratio 2025 |
40.5x | P/E ratio 2026 * | 31.6x |
|---|---|---|---|---|---|
| Enterprise value | 17.23B 14.52B 13.26B 12.65B 23.45B 1,560B 24.31B 154B 61.11B 752B 64.63B 63.29B 2,632B | EV / Sales 2025 |
6.44x | EV / Sales 2026 * | 5.24x |
| Free-Float |
95.72% | Yield 2025 * |
0.34% | Yield 2026 * | 0.36% |
Last Transcript: West Pharmaceutical Services, Inc.
| 1 day | -1.04% | ||
| 1 week | +2.77% | ||
| Current month | +5.40% | ||
| 1 month | -11.58% | ||
| 3 months | -12.18% | ||
| 6 months | +1.36% | ||
| Current year | -11.46% |
| 1 week | 227.49 |  | 259.9 |
| 1 month | 223.83 | | 281.55 |
| Current year | 223.83 | | 291.38 |
| 1 year | 187.43 | | 322.34 |
| 3 years | 187.43 | | 415.73 |
| 5 years | 187.43 | | 475.35 |
| 10 years | 55.23 | | 475.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Eric Green
CEO | Chief Executive Officer | 56 | 23/04/2015 |
Robert McMahon
DFI | Director of Finance/CFO | 57 | 03/08/2025 |
Quintin Lai
IRC | Investor Relations Contact | 59 | 10/01/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Hofmann
BRD | Director/Board Member | 74 | 15/10/2007 |
Mark Buthman
BRD | Director/Board Member | 65 | 31/01/2011 |
Douglas Michels
BRD | Director/Board Member | 69 | 06/03/2011 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +1.39% | 1.02% | 26 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.04% | +2.77% | -24.44% | -10.15% | 17.71B | |
| -1.87% | +3.02% | -15.19% | +3.06% | 198B | |
| -0.20% | -0.94% | +10.61% | +20.54% | 130B | |
| -4.00% | +6.39% | +42.27% | +120.75% | 71.14B | |
| +1.19% | +3.77% | +49.71% | +102.13% | 62.02B | |
| -1.56% | -14.46% | -22.53% | -28.25% | 51.43B | |
| -1.00% | -0.85% | - | - | 37.48B | |
| -4.50% | -8.11% | -24.66% | -44.80% | 26.58B | |
| +0.31% | -7.59% | +9.34% | +26.62% | 23.88B | |
| -1.99% | +2.45% | -25.75% | +6.18% | 20.32B | |
| Average | -1.47% | +0.38% | -0.07% | +21.79% | 63.77B | |
| Weighted average by Cap. | -1.40% | +1.74% | +3.20% | +26.87% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 3.06B 2.58B 2.36B 2.25B 4.17B 277B 4.32B 27.33B 10.86B 134B 11.49B 11.25B 468B | 3.24B 2.73B 2.5B 2.38B 4.41B 294B 4.58B 28.94B 11.5B 142B 12.16B 11.91B 495B |
| Net income | 498M 419M 383M 366M 677M 45.07B 702M 4.44B 1.77B 21.73B 1.87B 1.83B 76.05B | 561M 472M 431M 412M 763M 50.76B 791M 5B 1.99B 24.47B 2.1B 2.06B 85.66B |
| Net Debt | -477M -402M -367M -350M -649M -43.17B -673M -4.26B -1.69B -20.81B -1.79B -1.75B -72.85B | -719M -605M -553M -528M -978M -65.05B -1.01B -6.41B -2.55B -31.36B -2.69B -2.64B -110B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/02/26 | 243.61 $ | -1.04% | 2,173,517 |
| 11/02/26 | 246.16 $ | +1.07% | 1,656,569 |
| 10/02/26 | 243.56 $ | -2.16% | 1,172,550 |
| 09/02/26 | 248.93 $ | -0.01% | 1,048,745 |
| 06/02/26 | 248.95 $ | +7.48% | 1,481,074 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- WST Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition